Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen US-DRUG Not yet graded
US: bla
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010125
Compound index — N
422 substances begin with N. 4 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Neisseria Meningitidis… – Novobiocin.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedJ07AH08; J07AH11
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010126
Neisseria Meningitidis Group B Fhbp Fusion Protein Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010127
Neisseria meningitidis group B fHBP protein subfamily A EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07AH11
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010128
Neisseria meningitidis group B fHBP protein subfamily B EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07AH11
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010129
Neisseria Meningitidis Group B Nada Protein Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010130
Neisseria Meningitidis Group B Nhba Fusion Protein Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010131
Neisseria Meningitidis Group B Recombinant LP2086 A05 Protein Variant Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010132
Neisseria Meningitidis Group B Recombinant LP2086 B01 Protein Variant Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010133
Neisseria Meningitidis Group B Strain NZ98/254 Outer Membrane Vesicle Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010134
Neisseria Meningitidis Group C Capsular Oligosaccharide Diphtheria CRM197 Protein Conjugate Antigen US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Inactivated Meningococcal Vaccine [EPC]; Inactivated [CS]; Meningococcal Vaccines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010135
Neisseria Meningitidis Group C Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Inactivated Meningococcal Vaccine [EPC]; Inactivated [CS]; Meningococcal Vaccines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010136
Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen US-DRUG Not yet graded
US: bla
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010137
Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedJ07AH08; J07AH11
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010138
Neisseria meningitidis group W polysaccharide conjugated to tetanus toxoid EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07AH11
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010139
Neisseria Meningitidis Group W-135 Capsular Oligosaccharide Diphtheria CRM197 Protein Conjugate Antigen US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Inactivated Meningococcal Vaccine [EPC]; Inactivated [CS]; Meningococcal Vaccines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010140
Neisseria Meningitidis Group W-135 Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Inactivated Meningococcal Vaccine [EPC]; Inactivated [CS]; Meningococcal Vaccines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010141
Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen US-DRUG Not yet graded
US: bla
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010142
Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07AH08
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010143
Neisseria Meningitidis Group Y Capsular Oligosaccharide Diphtheria CRM197 Protein Conjugate Antigen US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Inactivated Meningococcal Vaccine [EPC]; Inactivated [CS]; Meningococcal Vaccines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010144
Neisseria Meningitidis Group Y Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Inactivated Meningococcal Vaccine [EPC]; Inactivated [CS]; Meningococcal Vaccines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010145
Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen US-DRUG Not yet graded
US: bla
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010146
Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedJ07AH08; J07AH11
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010147
Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily A EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07AH09
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010148
Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily B EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07AH09
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010149
Neisseria Meningitidis Serogroup B Recombinant LP2086 A05 Protein Variant Antigen US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010150
Neisseria Meningitidis Serogroup B Recombinant LP2086 B01 Protein Variant Antigen US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010151
Nekemias grossedentata CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010152
Neladalkib US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010153
Nelarabine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedL01BB07; Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
Earliest US approval2005
Market presence23 US product listings · 11 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010154
nelfinavir EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: nda
Class as recordedCytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; J05AE04; Protease Inhibitor [EPC]
Earliest US approval1997
Market presence2 US product listings · 3 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010155
Nelumbo Nucifera Flower US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010157
Nelumbo Nucifera Seed US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010158
Nemolizumab EU-MEDUS-DRUG Not yet graded
Nemolizumab-Ilto US-DRUG Not yet graded
Earliest US approval2024
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010160
Neodymium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Calcium [CS]; Calcium [EPC]; Cell-mediated Immunity [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010161
Neodymium Oxide US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ascorbic Acid [CS]
Market presence22 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010162
Neomycin US-DRUG Not yet graded
US: anda
Class as recordedAmide Local Anesthetic [EPC]; Amides [CS]; Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]
Earliest US approval1954
Market presence375 US product listings · 107 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010163
Neon US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAmino Acids; Aromatic Amino Acid [EPC]; Aromatic [CS]; Calculi Dissolution Agent [EPC]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010164
Neopicrorhiza scrophulariiflora CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010165
NeOpuntia®, containing dehydrated leaves of the prickly pear cactus (Opuntia ficus-indica) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “NeOpuntia® helps to improve blood lipid parameters associated with cardiovascular risks, especially the HDL-cholesterol.” | Non-authorised | Art.14(1)(a) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010166
Neopyropia leucosticta EU-NOVEL Not yet graded
Not novel in food
also: Porphyra leucosticta Thuret, Pyropia leucosticta (Thuret) Neefus & J.Brodie
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010167
Neopyropia yezoensis EU-NOVEL Not yet graded
Not novel in food
also: Porphyra yezoensis Ueda 1932, Pyropia yezoensis (Ueda) M.S.Hwang & H.G.Choi 2011, Porphyra palleola M.Noda 1964
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010168
Neostigmine Methylsulfate US-DRUG Not yet graded
US: anda
Class as recordedAnticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
Earliest US approval2013
Market presence65 US product listings · 21 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010169
Nepafenac EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Non-Steroidal [CS]; Nonsteroidal Anti-inflammatory Drug [EPC]
Earliest US approval2005
Market presence12 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010170
Nepenthes CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010171
Nepeta cataria CA-NHP Not yet graded
CA licensed ingredient
Market presence152 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010172
Nepeta tenuifolia CA-NHPEU-NOVEL Not yet graded
Nephelium lappaceum EU-NOVEL Not yet graded
Not novel in food
also: Dimocarpus crinitus Lour.
Parts in scopeFruit (berry)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010174
Neratinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedKinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; L01EH02; P-Glycoprotein Inhibitors [MoA]
Earliest US approval2017
Market presence5 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010176
Neridronic Acid US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010177
Nerinetide Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010178
Nerium oleander CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010179
Nerium Oleander Leaf US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence35 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010180
Nerium Oleander Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010181
Nerve Growth Factor US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAscorbic Acid [CS]; Depigmenting Activity [PE]; Melanin Synthesis Inhibitor [EPC]; Melanin Synthesis Inhibitors [MoA]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010182
Nesiritide US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2001
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010183
Netarsudil EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedRho Kinase Inhibitor [EPC]; Rho Kinase Inhibitors [MoA]; S01EX05
Earliest US approval2017
Market presence4 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010184
Netarsudil Dimesylate US-DRUG Not yet graded
Earliest US approval2019
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010185
netarsudil mesilate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedS01EE
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010186
Netilmicin Sulfate US-DRUG Not yet graded
Earliest US approval1983
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010187
Netupitant EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedA04AA; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]
Earliest US approval2014
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010188
Neuropeptide Y US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010189
Neurospora Intermedia US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010190
Neurospora Sitophila US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010191
Neurotensin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010192
Neurotrophin-3 US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010193
Neurotrophin-4 US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010194
Nevirapine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedCytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; J05AG01
Earliest US approval1996
Market presence21 US product listings · 53 FDA applications · 2 EU medicines
Etalyn identifierETA-C-010195
Newcastle disease EU-MED Not yet graded
EU medicine: Authorised
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010196
Newcastle disease and Marek's disease vaccine (live recombinant) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010197
Newcastle disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence4 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010198
Niacin CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 6 authorised / 2 refusedCA licensed ingredientUS: anda
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Earliest US approval1957
Market presence68 US product listings · 36 FDA applications · 4,100 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Niacin contributes to normal psychological function” | Authorised | Art.13(1) | EFSA opinion |
| “Niacin contributes to normal energy-yielding metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Niacin contributes to normal functioning of the nervous system” | Authorised | Art.13(1) | EFSA opinion |
| “Niacin contributes to the maintenance of normal mucous membranes” | Authorised | Art.13(1) | EFSA opinion |
| “Niacin contributes to the maintenance of normal skin” | Authorised | Art.13(1) | EFSA opinion |
| “Niacin contributes to the reduction of tiredness and fatigue” | Authorised | Art.13(1) | EFSA opinion |
| “[In german : ] Wichtig für den Blutfluss der Gefäße Clarification provided Important for vascular blood flow” | Non-authorised | Art.13(1) | EFSA opinion |
| “Niacin (nicotinic acid) may help to control blood lipid profiles/cholesterol/ triglycerides” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-010199
Niacinamide CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Adrenergic alpha-Agonists [MoA]
Earliest US approval1947
Market presence207 US product listings · 16 FDA applications · 4,864 Canadian licensed products
Etalyn identifierETA-C-010200
Nicardipine US-DRUG Not yet graded
US: anda
Class as recordedCalcium Channel Antagonists [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
Earliest US approval1988
Market presence61 US product listings · 30 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010201
Niccolum carbonicum CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010202
Niccolum metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010203
Niccolum sulphuricum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010204
Nickel CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]
Market presence104 US product listings · 258 Canadian licensed products
Etalyn identifierETA-C-010205
Nickel Ammonium Sulfate US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010206
Nickel Arsenide US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010207
Nickel Carbonate Hydroxide Tetrahydrate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010208
Nickel Fluoride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010209
Nickel Sulfate Hexahydrate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Copper [CS]
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010210
Niclosamide US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010211
Niclosamide-Olamine US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010212
Nicocodeine US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010213
Nicomorphine US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesVilan
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010214
Nicotiana tabacum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010215
Nicotiana Tabacum Whole US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010216
Nicotinamide CA-NHP Not yet graded
CA licensed ingredient
Market presence36 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010217
Nicotinamide Adenine Dinucleotide CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in supplementsCA licensed ingredientUS: bulk ingredient
Class as recordedAscorbic Acid [CS]; Vitamin C [EPC]; Vitamin D [CS]; Vitamin D [EPC]
Market presence21 US product listings · 2 Canadian licensed products
Parts in scopeSubstance
Etalyn identifierETA-C-010218
Nicotinamide Mononucleotide CA-NHPETALYNEU-NOVELUS-DRUG B/not supportedband 5
Nicotinamidum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010221
Nicotine CA-NHPETALYNUS-DRUG B/supportedband 1
CA licensed ingredientUS: anda
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]; Cholinergic Nicotinic Agonist [EPC]
Earliest US approval1991
Market presence844 US product listings · 7 FDA applications · 17 Canadian licensed products
Etalyn identifierETA-C-010222
Nicotine Polacrilex US-DRUG Not yet graded
Earliest US approval1984
Market presence56 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010223
Nicotine resinate CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010224
Nicotinum CA-NHP Not yet graded
CA licensed ingredient
Market presence28 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010226
Nifedipine US-DRUG Not yet graded
US: anda
Class as recordedCalcium Channel Antagonists [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
Earliest US approval1981
Market presence157 US product listings · 36 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010227
Nifurtimox US-DRUG Not yet graded
US: nda
Earliest US approval2020
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010228
Nigella Sativa Seed US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010230
Nikkomycin Z US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010231
Nilotinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
also: Nilotinib Trifluoroacetate
Class as recordedBcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]
Earliest US approval2007
Market presence53 US product listings · 9 FDA applications · 2 EU medicines
Etalyn identifierETA-C-010232
Nilotinib D-Tartrate US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010233
Nilutamide US-DRUG Not yet graded
US: anda
Class as recordedAndrogen Receptor Antagonists [MoA]; Androgen Receptor Inhibitor [EPC]
Earliest US approval1996
Market presence3 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010234
Nimesulide US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010235
Nimetazepam US-CSA Not yet graded
CSA Schedule IV
Class as recordedDEA: depressant
DEA other namesErimin
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010236
Nimodipine US-DRUG Not yet graded
US: anda
Class as recordedCalcium Channel Antagonists [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
Earliest US approval1988
Market presence14 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010237
nimotuzumab EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010238
Nintedanib EU-MEDUS-DRUG Not yet graded
Niobium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ascorbic Acid [CS]
Market presence26 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010240
Niobium Pentachloride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010241
Niobium Pentaiodide US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010242
Nipocalimab-Aahu US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010244
Niraparib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
Earliest US approval2017
Market presence19 US product listings · 3 FDA applications · 2 EU medicines
Etalyn identifierETA-C-010245
Nirogacestat EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedCytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Gamma Secretase Inhibitor [EPC]; Gamma Secretase Inhibitors [MoA]
Earliest US approval2023
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010247
Nirsevimab EU-MEDUS-DRUG Not yet graded
Nirsevimab-Alip US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010249
Nisoldipine US-DRUG Not yet graded
US: anda
Class as recordedCalcium Channel Antagonists [MoA]; Decreased Blood Pressure [PE]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
Earliest US approval1995
Market presence10 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010250
Nitazoxanide US-DRUG Not yet graded
US: anda
Class as recordedAntiprotozoal [EPC]
Earliest US approval2002
Market presence12 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010251
Nitenpyram US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010252
Nitisinone EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recorded4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]; A16AX04; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 2E1 Inducers [MoA]
Earliest US approval2002
Market presence33 US product listings · 7 FDA applications · 3 EU medicines
Etalyn identifierETA-C-010253
Nitrate ION US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010255
Nitrate(1-) CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010254
Nitrazepam US-CSA Not yet graded
CSA Schedule IV
Class as recordedDEA: depressant
DEA other namesMogadon
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010256
Nitri spiritus dulcis CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010257
Nitric Acid CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence191 US product listings · 1 Canadian licensed products
Etalyn identifierETA-C-010258
Nitric acid potassium salt (1:1) CA-NHP Not yet graded
CA licensed ingredient
Market presence96 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010259
Nitric acid silver(1+) salt (1:1) CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010260
Nitric acid sodium salt CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010261
Nitric Oxide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Nitrate Vasodilator [EPC]
Earliest US approval1999
Market presence11 US product listings · 4 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010262
Nitricum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence74 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010263
Nitrofurantoin US-DRUG Not yet graded
US: anda
Class as recordedNitrofuran Antibacterial [EPC]; Nitrofurans [CS]
Earliest US approval1953
Market presence240 US product listings · 34 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010264
Nitrofurantoin, Macrocrystalline US-DRUG Not yet graded
Earliest US approval1970
Market presence28 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010265
Nitrofurazone US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1945
Market presence4 US product listings · 11 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010266
Nitrogen US-DRUG Not yet graded
US: nda
also: Nitrogen, NF
Class as recordedAllergens [CS]; Calcium [CS]; Calcium [EPC]; Cell-mediated Immunity [PE]
Earliest US approval2013
Market presence141 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010267
Nitrogenum oxygenatum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010268
Nitroglycerin US-DRUG Not yet graded
US: anda
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Earliest US approval1981
Market presence201 US product listings · 65 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010269
Nitromuriaticum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010270
Nitroscanate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010271
Nitrous Oxide US-DRUG Not yet graded
US: nda
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Earliest US approval2013
Market presence49 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010272
Nitroxinil US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010273
Nivolumab EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bla
Class as recordedEndoglycosidase [EPC]; Glycoside Hydrolases [CS]; L01FF01; L01FY02
Earliest US approval2014
Market presence12 US product listings · 5 FDA applications · 3 EU medicines
Etalyn identifierETA-C-010274
Nizatidine US-DRUG Not yet graded
US: anda
Class as recordedHistamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
Earliest US approval1988
Market presence11 US product listings · 13 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010275
NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) US-CSA Not yet graded
CSA Schedule I
also: NM2201; CBL2201 -1H-indole-3-carboxylate)
Class as recordedDEA: hallucinogen / synthetic cannabinoid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010276
Nogapendekin Alfa Inbakicept-Pmln US-DRUG Not yet graded
US: bla
Class as recordedInterleukin-15 Receptor Agonist [EPC]; Interleukin-15 Receptor Agonists [MoA]
Earliest US approval2024
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010278
non-cytopathic parent strain KE-9 and modified live bovine viral diarrhoea virus type 2 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010280
non-cytopathic parent strain NY-93 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010281
Non-digestible carbohydrates EU-CLAIM Not yet graded
EU claims 1 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Consumption of foods/drinks containing <name of all used non-digestible carbohydrates> instead of sugars induces a lower blood glucose rise after their consumption compared to sugar-containing foods/drinks.” | Authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010742
Non-digestible oligo- and polysaccharides including galacto- oligosaccharides, oligofructose, polyfructose and inulin EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “With non-digestible oligo- and/ or polysaccharides to stimulate calcium absorption” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010743
non-expanded EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB05AX04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010282
Non-isolated fulvic acid EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-010284
nonacog alfa EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB02BD04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010285
nonacog beta pegol EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB02BD04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010286
nonacog gamma EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB02BD04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010287
Nonathymulin US-DRUG Not yet graded
US: bulk ingredient
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010288
Noni Fruit Juice US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010289
Nonivamide US-DRUG Not yet graded
US: otc monograph drug
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010290
NONOXYNOL-9 US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1963
Market presence3 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010291
Noracymethadol US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010292
Noradrenaline Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010293
Norbolethone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesGenabol
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010294
Norclostebol US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesAnabol-4-19; Lentabol
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010295
Nordiazepam US-CSA Not yet graded
CSA Schedule IV
Class as recordedDEA: depressant
DEA other namesNordazepam; Demadar; Madar
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010296
Norelgestromin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedEstrogen Receptor Agonists [MoA]; Estrogen [EPC]; G03AA13; Progesterone Congeners [CS]
Earliest US approval2001
Market presence13 US product listings · 5 FDA applications · 1 EU medicines
Etalyn identifierETA-C-010297
Norelgestromin || Ethinyl Estradiol US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010298
Norepinephrine US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Earliest US approval1950
Market presence64 US product listings · 27 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010299
Norethandrolone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesNilevar; Pronabol; Solevar
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010300
Norethindrone US-DRUG Not yet graded
US: anda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]
Earliest US approval1962
Market presence91 US product listings · 209 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010301
norethisterone acetate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedH01CC54
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-010302
Norethynodrel US-DRUG Not yet graded
Earliest US approval1961
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010303
Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) US-CSA Not yet graded
CSA Schedule IInarcotic
also: Norfentanyl propionamide)
Class as recordedDEA: precursor / immediate precursor
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010304
Norfloxacin US-DRUG Not yet graded
Earliest US approval1986
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010305
Norgestimate US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1989
Market presence5 US product listings · 37 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010306
Norgestrel US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1968
Market presence8 US product listings · 12 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010307
Norlevorphanol US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010308
Normethadone US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesPhenyldimazone
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010309
Normethandrolone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesLutenin; Matronal; Orgasteron
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010310
Normorphine US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010311
Noroxymorphone US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010312
Norpipanone US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-010313
Northern Bluefin Tuna US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010314
Northern Brown Shrimp US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010315
Northern Quahog US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010316
Nortriptyline Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedTricyclic Antidepressant [EPC]
Earliest US approval1964
Market presence94 US product listings · 15 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010317
Norwalk Virus US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010319
Noscapine US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010320
Notoginseng CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010321
Notopterygium forbesii CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010322
Notopterygium incisum CA-NHP Not yet graded
CA licensed ingredient
Market presence56 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010323
Novobiocin US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1964
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-010324